Skip to main content

Edwards Lifesciences

(EW) - Get Edwards Lifesciences Corporation Report

, a maker of products for heart disease, said Tuesday that it launched LifeStent FlexStar and FlexStar XL stent delivery systems in the U.S.

FlexStar systems are designed to optimize the delivery of Edwards' LifeStent nitinol self-expanding stents, which feature a triple-helix design and are currently approved for biliary indication in the U.S. LifeStent FlexStar delivery systems offer clinicians multiple methods for stent deployment to accommodate individual preference, the Irvine, Calif.-based company said.

TheStreet Recommends

"The FlexStar delivery system's design allows the user increased deployment accuracy, taking advantage of LifeStent's flexibility and radial strength," the company said. "LifeStent FlexStar self-expanding stent delivery systems are designed for use in some of the most challenging cases."

The shares of the company were trading up 3 cents at $46.52 Tuesday.

This story was created through a joint venture between and IRIS.